M. Suttorp Et Al. , "Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients," PEDIATRIC BLOOD & CANCER , vol.65, no.12, 2018
Suttorp, M. Et Al. 2018. Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients. PEDIATRIC BLOOD & CANCER , vol.65, no.12 .
Suttorp, M., Metzler, M., Millot, F., Shimada, H., Bansal, D., Gunes, A., ... Kalwak, K.(2018). Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients. PEDIATRIC BLOOD & CANCER , vol.65, no.12.
Suttorp, Meinolf Et Al. "Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients," PEDIATRIC BLOOD & CANCER , vol.65, no.12, 2018
Suttorp, Meinolf Et Al. "Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients." PEDIATRIC BLOOD & CANCER , vol.65, no.12, 2018
Suttorp, M. Et Al. (2018) . "Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients." PEDIATRIC BLOOD & CANCER , vol.65, no.12.
@article{article, author={Meinolf Suttorp Et Al. }, title={Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patients}, journal={PEDIATRIC BLOOD & CANCER}, year=2018}